Envoy’s mission is to discover new drugs that will help millions of people. Our bacTRAP® technology creates an unprecedented view into the protein expression profiles of specific cell types within the body and is particularly powerful in the brain. Using it, we have identified highly specific drug targets and are building a portfolio of promising new compounds for neurological and psychiatric diseases. Three preeminent venture capital firms have invested in us, and pharmaceutical partners have begun to form research alliances with us.